FYR Diagnostics
Missoula, US · Founded 2020 · Delaware corporation · 1 known investors
Founders & leadership
BC
Brian ConwayExecutive
CB
Christopher BoothExecutive
SP
Sarjubhai PatelNamed on SEC filing
Board
MG
AS
Investors · 1
Reported raises · per SEC filings
Form D private placements$8M disclosed across 1 round · 2024
▶$8MraisedAug 2024 · 2 investors · BiotechnologyRule 506(b)
▶$8MraisedAug 2024 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Brian ConwayExecutive Officer
- Michael GoguenDirector
- Avery SonnenbergDirector
- Sarjubhai PatelExecutive Officer, Director
- Christopher BoothExecutive Officer, Director
- Offering amount
- $12M
- Amount sold
- $8M
- First sale
- Aug 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 3 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2021 | $351.1K |
| National Science Foundation | Phase I | 2021 | $256K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2019 | $618.1K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who are FYR Diagnostics's investors?
- FYR Diagnostics's investors include Two Bear Capital.
- How much funding has FYR Diagnostics raised?
- FYR Diagnostics has disclosed $8M raised across 1 round.
- Where is FYR Diagnostics headquartered?
- FYR Diagnostics is headquartered in Missoula, US.